Document Detail

Association of leukocyte and neutrophil counts with infarct size, left ventricular function and outcomes after percutaneous coronary intervention for ST-elevation myocardial infarction.
MedLine Citation:
PMID:  19166685     Owner:  NLM     Status:  MEDLINE    
Elevated leukocyte count during ST-segment elevation myocardial infarction is associated with adverse clinical outcomes. Whether increased leukocyte count after primary percutaneous coronary intervention (PCI) directly reflects larger infarct size and left ventricular impairment is not known. The aim of this study was to assess the relation between leukocyte and neutrophil counts with infarct size and the left ventricular ejection fraction (LVEF) after primary PCI. Three hundred sixty-three patients from the Evaluation of MCC-135 for Left Ventricular Salvage in Acute Myocardial Infarction (EVOLVE) study, a randomized, double-blind, placebo-controlled trial assessing the efficacy of intracellular calcium modulator as an adjunct to primary PCI in patients with first ST-segment elevation myocardial infarctions, were evaluated. Total and differential leukocyte counts were measured before and serially after PCI. Infarct size and the LVEF were assessed using single-photon emission computed tomography after 5 and 30 days, and patients were followed up to 180 days. Total leukocyte and neutrophil counts obtained 24 hours after PCI were significantly correlated with infarct size (r = 0.34 and 0.37, respectively, p <0.001) and inversely correlated with the LVEF (r = -0.20 and -0.22, respectively, p <0.001). Patients with elevated leukocyte and neutrophil counts had larger infarct sizes (12.5% vs 5% and 13.5% vs 5%, respectively, p <0.001). The highest neutrophil quartile was associated with increased 180-day composite cardiac events (19% vs 20% vs 23% vs 45%, log-rank p <0.001). Elevated leukocyte and neutrophil counts independently predicted adverse cardiac events (hazard ratios 2.5 and 2.2, respectively, p = 0.001). In conclusion, elevated leukocyte and neutrophil counts after primary PCI in patients with ST-segment elevation myocardial infarctions are directly related to myocardial infarct size and the LVEF and are independent predictors of cardiovascular outcomes.
Stanley Chia; John T Nagurney; David F M Brown; O Christopher Raffel; Fabian Bamberg; Fred Senatore; Frans J Th Wackers; Ik-Kyung Jang
Related Documents :
12384635 - Eptifibatide in percutaneous coronary intervention. a review.
12208405 - Comparison of enoxaparin versus unfractionated heparin in patients with unstable angina...
24620215 - Two biomarkers for the screening of cardiac risk among runners?
24556195 - Participation in cardiac rehabilitation, readmissions and death after acute myocardial ...
25021005 - Pmm.08 pulmonary oedema in pregnancy and the puerperium - a review of 53 cases.
23336965 - Ruptured left ventricular pseudoaneurysm in the mediastinum following acute myocardial ...
Publication Detail:
Type:  Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't     Date:  2008-11-17
Journal Detail:
Title:  The American journal of cardiology     Volume:  103     ISSN:  1879-1913     ISO Abbreviation:  Am. J. Cardiol.     Publication Date:  2009 Feb 
Date Detail:
Created Date:  2009-01-26     Completed Date:  2009-02-11     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0207277     Medline TA:  Am J Cardiol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  333-7     Citation Subset:  AIM; IM    
Heart Center, Massachusetts General Hospital, Boston, MA, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Angioplasty, Transluminal, Percutaneous Coronary*
Double-Blind Method
Leukocyte Count*
Middle Aged
Myocardial Infarction / blood,  physiopathology,  radionuclide imaging,  therapy*
Stroke Volume*
Tomography, Emission-Computed, Single-Photon

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Hematologic parameters, atherosclerotic progression, and prognosis in patients with previous coronar...
Next Document:  Cost-effectiveness of drug-eluting stents including the economic impact of late stent thrombosis.